GSK’s oncology and HIV drugs drive 7% sales rise in 2025
GSK has posted positive sales results for fiscal year 2025 (FY2025) as the company’s new CEO, Luke Miels, takes the…
Infectious Disease
-
-
JPM26: Enanta outlines strategy to lead in RSV therapeutics
At the 44th Annual J.P. Morgan Healthcare Conference, Enanta Pharmaceuticals discussed its respiratory syncytial virus (RSV) portfolio and the need…
-
“Reckless and harmful”: experts weigh in on CDC’s autism-vaccine link stance
The Centers for Disease Control and Prevention (CDC) has updated its website to state that there could be a link…
-
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has agreed to acquire Cidara Therapeutics in a $9.2bn deal, adding a new long-lasting infectious disease drug technology to…
-
Flu vaccine uptake increases 28% in England
The number of people receiving a flu vaccine across England has increased by over a quarter, as cases of both…
-
Basilea in line for $159m of US federal funding for UTI antibiotic pill
The Biomedical Advanced Research and Development Authority (BARDA) in the US will support Basilea’s development of a new type of…
-
US Government signs $56m smallpox/mpox vaccine order despite political disarray
The US Government has ordered $56m worth of mpox/smallpox vaccines to bolster public health preparedness, despite wider uncertainty in the…
-
Gilead’s Yeytuo approved in EU, boosting its blockbuster potential
The European Commission (EC) has approved Gilead’s Yeytuo (lenacapavir) for the prevention of HIV infection, consolidating the injectable drug’s potential…
-
Moderna’s updated Covid-19 vaccine gets Canadian approval
Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 LP.8.1 variant.…
-
FDA approves Papzimeos as first therapy for HPV-caused airway disease
The US Food and Drug Administration (FDA) has approved the first treatment for recurrent respiratory papillomatosis (RRP), a rare respiratory…
